controversies in colorectal cancer
TRANSCRIPT
Controversies in Colorectal Surgery
Atthaphorn Trakarnsanga MD FRCSTDepartment of Surgery, Faculty of Medicine Siriraj Hospital
Mahidol University, Bangkok, Thailand
No Disclosure
Topics
• Surgery for locally advanced rectal cancer- Optimal timing of surgery after nCCRT- Organ preservation
(Local excision, “wait and see”)
Locally advanced rectal cancer • T3 or T4 and/or N +• Preoperative clinical staging
- CT scan - Endorectal ultrasonography - MRI
• Neoadjuvant chemoradiation (50.4 Gy combined with 5-FU based regimen)
Accuracy CT ERUS MRI
T Stage 73 87 82
N Stage 66 74 74
Kwok et al. Int J Colorectal Dis 2000;15:9-20
Neoadjuvant Chemoradiation
nCCRT TME adj CMT6-8 weeks 4-6 weeks
Francois Y J Clin Oncol 199917:2396
The Lyon R90-01 randomized trial - Short interval (within 2 wk) vs. Long interval (6-8 wk)- Significant better tumor response in long interval group (71.7% vs. 53.1%, p= 0.007)- No detrimental effect on toxicity
Neoadjuvant Chemoradiation
nCCRT TME adj CMT6-8 weeks 4-6 weeks
Increased waiting time
Increased tumor regression (pCR?)
Neoadjuvant Chemoradiation
nCCRT TME adj CMT6-8 weeks 4-6 weeks
Increased waiting time
Increased tumor regression (pCR?)
Increased fibrosis formation (complications?)
nCCRT TME adj CMT6-8 weeks 4-6 weeks
The median volume-halving time was 14 days
Week after CCRT
2 4 6 8 10 12 14 16 18 20
% regression
50 25 12.5 6.25 3.13 1.56 0.78 0.39 0.19 0.09
Tumor volume(cm3)
27 13.5 6.7 3.3 1.6 0.8 0.4 0.2 0.1 0.05
Mean Tumor volume = 54 cm3 Dhadda A.S. et al. Clinical Oncology 2009; 21: 23-31
Optimal Timing of Surgery after nCCRT
nCCRT TME adj CMT6-8 weeks 4-6 weeks
Increased waiting time
Waiting 10-11 weeks following nCCRT leads to highest chance for pCRSloothaak DA et al. Br J Surg 2013
Optimal Timing of Surgery after nCCRT
Siriraj’s experiences • Retrospective review from prospective
maintained data.
• Sixty patients of locally advanced rectal cancer
(T3-4 and/or N+ by CT scan, ERUS and/or MRI)
from Jun 2012 to Jan 2015
• Long-course chemoradiotherapy
Presented at World Congress of Surgery 2015, Bangkok, Thailand
Cilincal T staging
0.89
T3 14 (82%) 36 (83%)
T4 3 (18%) 7 (17%)
Clinical N positive 0.31
Negative 2 (12%) 10 (23%)
Positive 15 (88%) 33 (76%)
Distance from AV, cm 4.5 (3.4,5.7) 5.6 (4.9,6.3) 0.17
Variable Within 8 Wk (n=17)
More than 8 Wk (n=43)
P value
Values are presented as mean (95% CI), or number(%)
Values are presented as mean (95% CI), or number(%)
Variable Within 8 Wk (n=17) More than 8 Wk (n=43)
Duration after complete nCCRT to surgery ,weeks
6.4 (5.7 , 7.0) 11.7 (10.8 , 12.7)
VariableWithin 8 Wk
(n=17)More than 8 Wk
(n=43) P value
Operative time, min 277 (234, 320) 255 (223 , 286) 0.43 Estimate blood loss, ml 374 (196 , 551) 360 (239 , 481) 0.90 Blood transfusion, unit 0.4 (0 , 0.9) 0.3 (0.4 , 0.5) 0.5 Bowel movement, days 3 (2.3,3.6) 3.3 (2.7,4.0) 0.51 Full diet intake, days 4 (3,5) 3.7 (3.1,4.2) 0.58 Postoperative LOS, days 8.0 (6.0,10.1) 8.6 (6.0,11.1) 0.79
Values are presented as mean (95% CI), or number(%)
Grade 1 0 1
Grade 2 1 5
Grade 3a 0 0
Grade 3b 2 1
Grade 4 0 0
Grade 5 0 0
Total 3 7 0.19
Clavien-Dindo classification
Within 8 Wk (n=17)
More than 8 Wk (n=43)
P value
Tumor characteristics Within 8 Wk (n=17)
More than 8 Wk (n=43)
P value
Tumor grading
Well diff. 1 (5.9%) 1 (2.3%)
Mod diff. 14 (82.3%) 35 (81.3%)
Poor diff. 2 (11.8%) 2 (4.7%)
Circumferential margin
Positive 5 (30%) 4 (9.3%) 0.04
Invasion
Perineural invasion 7 (41.1%) 16 (37.2%) 0.77
Lymphovascular invasion
2 (11.7%) 8 (18.6%) 0.52
PCR 2 (11.7%) 8 (18.6%) 0.52
• Extend waiting time from nCCRT to surgery (> 8 weeks) did not increase perioperative complications.
• R0 resection (circumferential margin >1mm) and rate of pCR were higher in extended waiting time group.
• Prospective randomized controlled trial is needed.
Siriraj’s experiences
Presented at World Congress of Surgery 2015, Bangkok, Thailand
Controversy Issue
• Timing of full dose chemotherapy is delayed in extended waiting time group
Dx Surgery CMT CMT/RT CMT
DX nCCRT Surgery CMT
DX nCCRT Surgery CMT
4-6 wk
4-6 wk6-8 wk
10-12 wk 4-6 wk
Controversy Issue
• Timing of full dose chemotherapy is delayed in extended waiting time group
Dx Surgery CMT CMT/RT CMT
DX nCCRT Surgery CMT
DX nCCRT Surgery CMT
4-6 wk
4-6 wk6-8 wk
10-12 wk 4-6 wk
4-6 weeks
10-14 weeks
14-18 weeks
Adding Chemotherapy in Waiting Period
nCRT TME adj CMT10-12 weeks 4-6 weeks
Increase timing +Add chemotherapy
Garcia-Aguilar J et al. Lancet Oncol 2015;16:957-66.
pCR 18%
pCR 25%
pCR 30%
pCR 38%
60
67
67
65
Complications are higher in adding chemotherapy groups
Trakarnsanga A et al. JNCI 2014; 106: dju248Trakarnsanga A et al. World J Gastroenterol 2013
Pathological Complete Response• No viable tumor after
resection (15-20%) • The chances of recurrence
are extremely low • Clinical complete response
may not equivalent to pCR• Surgery may not be
needed
Surgery following nCCRT• LAR: diverting stoma is
needed to reduced leakage symptoms
• 50% of elderly patients have not undergone stoma reversal
• Majority of patients develop changing of bowel function
• APR: associated with morbidity to the patients Mass M et al. J Clin Oncol 2011;29(35)
Clinical Complete Response• Diagnosis is challenged• DRE is an accurate method for determining response, overall
concordance was 22%*
• Accuracy for restaging in T stage is low for early stage (ERUS: >80% for T3 vs. 25% for T1)**
• Diffusion-weighted MRI is more accurate***• PET/CT has pooled accuracy sensitivity 73% and specificity
77%*****Guillem JG et al. J Clin Oncol 2005;23:3475-9
** Memon S et al. Colorectal Dis 2015;17:748-61*** Lambregts DMJ, et al. Ann Surg Oncol 2011;18:2224-31
**** Mafflone AM et al. AJR Am J Roentgenol 2015;204:1261-8
ERUS MRIAccuracy of T stage 65% (26-93) 52% (34-82)
Accuracy of N stage 73% (57-92) 72% (60-88)
Local excision after nCCRT• To access pathological response accurately
Versevald M Br J Surg 2015;102: 853-60
TEM after nCCRT enabled organ preservation in one-half
“Wait and see”
Chawla S et al. Am J Clin Oncol 2014
Glynne-Jones R and Hughes R Br J Surg 2012;99:897-909
Topics
• Surgery for locally advanced rectal cancer- Optimal timing of surgery after nCCRT- Organ preservation
(Local excision, “wait and see”)